Hartaj Singh

Work

Analyst Hartaj Singh works at OPPENHEIMER and is focused on the Healthcare sector with 181 price targets and ratings documented since 2015 spanning on 19 stocks. Previously, Hartaj Singh worked at BTIG. Analyst's average stock valuation to be materialised ratio is 56.88% with an average time for price targets to be met of 319.54 days.

Most recent stock forecast was given on GILD, Gilead Sciences, Inc at 01-Dec-2022.

Hartaj Singh best performing recommendations are on SNSS.
The best stock recommendation documented was for MRNA (MODERNA, INC) at 4/15/2020. The price target of $43 was fulfilled within 2 days with a profit of $5.75 (15.44%) receiving and performance score of 77.18.

Average potential price target upside

ALXN CATB GILD INO LIFE MRNA REGN SBBP SNSS UTHR VIRX VRTX SRPT ELOX BMEA FSTX ONCT SPRB GANX

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

205

$22.5 (12.33%)

1 years 9 months 1 days ago

4/6 (66.67%)

$35.77 (24.78%)

715

Hold

173

$-9.5 (-5.21%)

156

1 years 9 months 3 days ago

15/27 (55.56%)

$53.78 (43.26%)

659

Hold

190

$7.5 (4.11%)

190

1 years 9 months 11 days ago

12/15 (80%)

$25.6 (21.95%)

474

Buy

166

$-16.5 (-9.04%)

175

2 years 2 days ago

23/24 (95.83%)

$57.5 (50.98%)

786

Hold

155

2 years 29 days ago

11/11 (100%)

$47.59 (43.76%)

415

Show more analysts
ALXN CATB GILD INO LIFE MRNA REGN SBBP SNSS UTHR VIRX VRTX SRPT ELOX BMEA FSTX ONCT SPRB GANX